FOXP3 and COVID-19: It has also been reported that reduced CD4+FoxP3+ Tregs are present in COVID-19, but an increased frequency of TIGIT+ Tregs at the time of hospital admission, which correlates with severity, suggesting that a robust suppressive activity is associated with fatal outcomes (58).